PRIMAFUNGIN No. 6

  • Registration number:ЛП-000411
  • International non-proprietary name:natamycin
  • Pharmaceutical form:vaginal suppositories
  • Pharmacotherapeutic group:antifungal agents
  • Dosage form:vaginal suppositories, No. 6
  • Composition:Active substance: natamycin 100 mg; Suppository base: a unique patented form - Suppocire AM® for maximally even distribution of the active substance.

PRIMAFUNGIN® - a rational and convenient treatment of chronic vulvovaginal candidiasis (chronic thrush)

  • The medicinal product eradicates not only Candida albicans yeast, but also Candida non-albicans¹ yeast.
  • No cases of resistance in clinical practice¹
  • A unique base Suppocire AM® contributes to even distribution of active substance¹
  • The medicinal product can be used in all stages of pregnancy and during lactation¹

¹ Instructions for medical use of the medicinal product "Primafungin, vaginal suppositories", MA LP-000411 of May 10, 2017

Indications for use:

  • chronic recurrent vulvovaginal candidiasis (chronic thrush);
  • for prophylaxis during prolonged treatment with broad-spectrum antibiotics, glucocorticosteroids, or cytostatics.
Method of administration and posology:

Intravaginally.

For adult and young women (after initiation of sex), use 1 vaginal suppository for 3-6 days. Inject the suppositories as deep as possible into vagina in lying position once daily for a night. Suppositories should not be divided into parts, since such change of the drug storage conditions can lead to maldistribution of the active substance.

Shelf life:

2 years. Do not use after the expiry date.

Manufacturer
LLC "Avexima Siberia"
THERE ARE CONTRAINDICATIONS. READ THE INSTRUCTION OR CONSULT A MEDICAL SPECIALIST BEFORE USE